338 related articles for article (PubMed ID: 38638604)
1. Insights from the neural guidance factor Netrin-1 into neurodegeneration and other diseases.
Cai M; Zheng Q; Chen Y; Liu S; Zhu H; Bai B
Front Mol Neurosci; 2024; 17():1379726. PubMed ID: 38638604
[TBL] [Abstract][Full Text] [Related]
2. Netrin-1: An emerging player in inflammatory diseases.
Xia X; Hu Z; Wang S; Yin K
Cytokine Growth Factor Rev; 2022 Apr; 64():46-56. PubMed ID: 35082104
[TBL] [Abstract][Full Text] [Related]
3. Netrin-1 receptor UNC5C cleavage by active δ-secretase enhances neurodegeneration, promoting Alzheimer's disease pathologies.
Chen G; Kang SS; Wang Z; Ahn EH; Xia Y; Liu X; Sandoval IM; Manfredsson FP; Zhang Z; Ye K
Sci Adv; 2021 Apr; 7(16):. PubMed ID: 33863723
[TBL] [Abstract][Full Text] [Related]
4. Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders.
Ramanan VK; Saykin AJ
Am J Neurodegener Dis; 2013 Sep; 2(3):145-75. PubMed ID: 24093081
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the netrin-1 gene cause congenital mirror movements.
Méneret A; Franz EA; Trouillard O; Oliver TC; Zagar Y; Robertson SP; Welniarz Q; Gardner RJM; Gallea C; Srour M; Depienne C; Jasoni CL; Dubacq C; Riant F; Lamy JC; Morel MP; Guérois R; Andreani J; Fouquet C; Doulazmi M; Vidailhet M; Rouleau GA; Brice A; Chédotal A; Dusart I; Roze E; Markie D
J Clin Invest; 2017 Nov; 127(11):3923-3936. PubMed ID: 28945198
[TBL] [Abstract][Full Text] [Related]
6. Netrin-1 in Post-stroke Neuroprotection: Beyond Axon Guidance Cue.
Luo Y; Liao S; Yu J
Curr Neuropharmacol; 2022; 20(10):1879-1887. PubMed ID: 35236266
[TBL] [Abstract][Full Text] [Related]
7. From cradle to grave: neurogenesis, neuroregeneration and neurodegeneration in Alzheimer's and Parkinson's diseases.
Wakhloo D; Oberhauser J; Madira A; Mahajani S
Neural Regen Res; 2022 Dec; 17(12):2606-2614. PubMed ID: 35662189
[TBL] [Abstract][Full Text] [Related]
8. Guiding synaptic plasticity: Novel roles for netrin-1 in synaptic plasticity and memory formation in the adult brain.
Glasgow SD; Ruthazer ES; Kennedy TE
J Physiol; 2021 Jan; 599(2):493-505. PubMed ID: 32017127
[TBL] [Abstract][Full Text] [Related]
9. A signaling mechanism coupling netrin-1/deleted in colorectal cancer chemoattraction to SNARE-mediated exocytosis in axonal growth cones.
Cotrufo T; Pérez-Brangulí F; Muhaisen A; Ros O; Andrés R; Baeriswyl T; Fuschini G; Tarrago T; Pascual M; Ureña J; Blasi J; Giralt E; Stoeckli ET; Soriano E
J Neurosci; 2011 Oct; 31(41):14463-80. PubMed ID: 21994363
[TBL] [Abstract][Full Text] [Related]
10. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
Šaponjić J
Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729
[TBL] [Abstract][Full Text] [Related]
11. New drug treatments show neuroprotective effects in Alzheimer's and Parkinson's diseases.
Hölscher C
Neural Regen Res; 2014 Nov; 9(21):1870-3. PubMed ID: 25558231
[TBL] [Abstract][Full Text] [Related]
12. Netrin-1 Interrupts Amyloid-β Amplification, Increases sAβPPα in vitro and in vivo, and Improves Cognition in a Mouse Model of Alzheimer's Disease.
Spilman PR; Corset V; Gorostiza O; Poksay KS; Galvan V; Zhang J; Rao R; Peters-Libeu C; Vincelette J; McGeehan A; Dvorak-Ewell M; Beyer J; Campagna J; Bankiewicz K; Mehlen P; John V; Bredesen DE
J Alzheimers Dis; 2016 Mar; 52(1):223-42. PubMed ID: 27060954
[TBL] [Abstract][Full Text] [Related]
13. Solving neurodegeneration: common mechanisms and strategies for new treatments.
Wareham LK; Liddelow SA; Temple S; Benowitz LI; Di Polo A; Wellington C; Goldberg JL; He Z; Duan X; Bu G; Davis AA; Shekhar K; Torre A; Chan DC; Canto-Soler MV; Flanagan JG; Subramanian P; Rossi S; Brunner T; Bovenkamp DE; Calkins DJ
Mol Neurodegener; 2022 Mar; 17(1):23. PubMed ID: 35313950
[TBL] [Abstract][Full Text] [Related]
14. Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology.
Coskuner-Weber O; Uversky VN
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364151
[TBL] [Abstract][Full Text] [Related]
15. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.
Goyal A; Verma A; Dubey N; Raghav J; Agrawal A
J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706
[TBL] [Abstract][Full Text] [Related]
16. Prolactin and Its Altered Action in Alzheimer's Disease and Parkinson's Disease.
Duc Nguyen H; Pal Yu B; Hoang NHM; Jo WH; Young Chung H; Kim MS
Neuroendocrinology; 2022; 112(5):427-445. PubMed ID: 34126620
[TBL] [Abstract][Full Text] [Related]
17. Multiple Functions of Draxin/Netrin-1 Signaling in the Development of Neural Circuits in the Spinal Cord and the Brain.
Ahmed G; Shinmyo Y
Front Neuroanat; 2021; 15():766911. PubMed ID: 34899198
[TBL] [Abstract][Full Text] [Related]
18. Netrin-1: A Modulator of Macrophage Driven Acute and Chronic Inflammation.
Ziegon L; Schlegel M
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008701
[TBL] [Abstract][Full Text] [Related]
19. An imbalance of netrin-1 and DCC during nigral degeneration in experimental models and patients with Parkinson's disease.
Hua Y; Han W; Zhou L; Gao J; Zhao J; Song N; Hu B; Yao Q; Liu Y; Xu D; Lu Y; Fan Y
CNS Neurosci Ther; 2023 Jul; 29(7):1817-1829. PubMed ID: 36852451
[TBL] [Abstract][Full Text] [Related]
20. Netrin-1-mediated axon guidance in mouse embryonic stem cells overexpressing neurogenin-1.
Hill GW; Purcell EK; Liu L; Velkey JM; Altschuler RA; Duncan RK
Stem Cells Dev; 2012 Oct; 21(15):2827-37. PubMed ID: 22512716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
